List view / Grid view
15 October 2018 | By European Pharmaceutical Review
The Dynamic Mass Spectrometry Probe uses microfluidic technology to help separate compounds of interest from the salts in less than a minute...
9 October 2018 | By European Pharmaceutical Review
In the future, venomous snakebites could be treated using nanoparticles to bind the venom toxins and prevent them from spreading around the body...
1 October 2018 | By Iqra Farooq (European Pharmaceutical Review)
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease...
27 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease...
25 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
A report has suggested that the biosimilars market growth will increase at a CAGR of 34.2 percent over the course of the period analysed...
24 September 2018 | By CPhI Worldwide
Record entries highlight a big year of innovation in pharma...
24 September 2018 | By Thermo Fisher Scientific
Supporting scientists through the collaborative development of next generation chromatography and mass spectrometry solutions in Pharma/Biopharma and Food/Beverage Industries...
24 September 2018 | By Roquette
Learn how Roquette supports customers in the development of innovative pharmaceutical formulations and new biopharma solutions...
19 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
Viruses explored through Radiance, an instrument designed to improve the process of analysis, ensures quick and efficient viral detection...
14 September 2018 | By Dr Nasr Asfahani
The investigation and development of new drugs is a time-consuming and rigorous process with many challenges. Every step and each new method is developed with the intention of bringing effective medicines to patients in the shortest possible time, while ensuring the highest possible level of safety. Good product design, as…
14 September 2018 | By Edislav Lekšić -Team Leader of Physical Sciences - Almac Group
The particle size of Active Pharmaceutical Ingredients (API) has a significant effect on a drug product’s manufacturability and performance. With respect to manufacturability, particle size can affect compatibility, flowability and blend uniformity; with respect to product performance it can affect solubility, dissolution, and bioavailability.
5 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
The NHS has announced a groundbreaking new treatment, CAR-T, for children with leukaemia...
30 August 2018 | By Daniela Cavagnino
Pharmaceutical products come into contact with a wide range of polymeric materials on their journey from the production line to patients. Plastic and rubber contact surfaces are present at almost every stage of a product’s lifecycle: they’re present in single-use systems, such as filters and tubing employed in manufacturing processes;…
29 August 2018 | By Peak Scientific
Modern laboratories use a number of gases as part of their daily operations. This application note details two of the most common methods of laboratory gas supply, and their associated safety risks and benefits...
29 August 2018 | By European Pharmaceutical Review
In this issue: investment in biopharmaceuticals, particle size methods, and unlocking the potential of new technologies like Lab-on-a-chip.
Follow: